News

Inside the Institute | January 10, 2017

Chowdhury receives Tina’s Wish funding for ovarian cancer research

Clifford Chance Today | December, 2016

Tina’s Wish to fund $1.6 million in grants for ovarian cancer research

PR Newswire | December 5, 2016

Tina’s Wish to Fund $1.6M in Grants for Eight Early Detection Ovarian Cancer Research Projects

Read full press release>

Learn more about our research>


OncLive | November 28, 2016

Levine Sheds Light on Precision Medicine in Gynecologic Malignancies

Read full article>

Dr. Levine is the Tina’s Wish Scientific Advisory Board Chair.


SELF | November 1, 2016

Cobie Smulders Had Ovarian Cancer At 25—Here Are The Symptoms You Should Know

Read full article>

Dr. Levine is the Tina’s Wish Scientific Advisory Board Chair.


Yale Daily News | October 18, 2016

Histone core genes significant to carcinosarcomas, study finds

Read full article>

Dr. Santin is a Tina’s Wish Consortium Grant recipient.


Clifford Chance Today | September, 2016

Tina’s Wish Benefit Raises US$1.4M for Early Detection Ovarian Cancer Research

Read full article>


PR Newswire | September 29, 2016

Tina’s Wish Benefit Raises $1.4M for Early Detection Ovarian Cancer Research at the American Museum of Natural History 

Read full article>


The Island Now | July 28, 2016

Event raises $110,000 to fight cancer

On July 21, Christopher and Lanie Marcus hosted their second annual reception to benefit Tina’s Wish, a nonprofit organization that funds research on early detection and prevention of ovarian cancer.

Read full article>


Port Washington Patch | July 25, 2016

Sands Point Event Raises $110K for Ovarian Cancer Research

A Sands Point couple held a summer reception to benefit the nonprofit Tina’s Wish.

Read full article>


Law360 | July 22, 2016

Tina Brozman Recognized As One of the Most Influential Bankruptcy Judges

From the Chandler Act in the late 1930s to the contemporary fast-paced brand of complex business restructuring, these judges left an indelible mark on the body of law and procedures that make up today’s corporate bankruptcy practice. Here, Law360 spoke with restructuring attorneys and experts to get their take on some of the giants of the bankruptcy bench.

Clifford Chance World Magazine | July, 2016

Fulfilling Tina’s Wish

New York Clifford Chance partner Andrew Brozman talks to World about losing his wife to ovarian cancer and his mission to help fund a breakthrough in early detection scientific research.

Read full article>


Oncology Nurse Advisor | April 14, 2016

Optimal Tumor Reduction, Platinum Sensitivity Characterize Long-term Ovarian Cancer Survival

A multicenter study led by Tina’s Wish Researcher, Douglas Levine, MD, of MSK shows that women who are long-term survivors of high-grade serous carcinoma ovarian cancer usually have platinum-sensitive disease and undergo optimal tumor reduction surgery.

Read full article>


Cancer Therapy Advisor | March 28, 2016

Paradigm Shift in Ovarian Cancer Points to Fallopian Tube as Site of Origin

In an interview with Cancer Therapy Advisor, Dr. Ronny Drapkin, MD, PhD, the Franklin Payne Chair in Gynecologic Oncology and director of the Penn Ovarian Cancer Research Center, spoke about how far management of ovarian cancer has come—and how far it still has to go. Read full article>

Dr. Ronny Drapkin is a Tina’s Wish grant recipient.


The Institute of Medicine of the National Academies of Sciences, Engineering, and Medicine | March 2, 2016

Ovarian Cancers: Evolving Paradigms in Research and Care

The Institute of Medicine of the National Academies of Sciences, Engineering, and Medicine Committee on the State of the Science in Ovarian Cancer Research, released their informative report Ovarian Cancers: Evolving Paradigms in Research and Care. The report identifies the research gaps that, if addressed, could have the greatest impact on reducing morbidity or mortality.

Read Report Brief and Press Release>


Dana-Farber Cancer Institute | February, 2016

Liu Briefs Congress on Importance of Federal Funding

Dr. Joyce Liu of Dana-Farber Cancer Institute discusses the importance of federal funding after her successful clinical trial, which was funded by the National Cancer Institute, proved that a novel two-drug combination nearly doubled progression-free survival for many women with ovarian cancer. Dr. Liu serves on the Tina’s Wish Scientific Advisory Board

Read article>


Controlled Environments | February 24, 2016

Nanotechnology Uses Light to Show Density of Tumors

Tina’s Wish grant recipient, Daniel Heller, PhD, of Memorial Sloan Kettering Cancer Center discusses his use of nanotechnology to demonstrate tumor density.

Read article>


Memorial Sloan Kettering On Cancer Blog | January 22, 2016

Are We Closer to Screening Average-Risk Women for Ovarian Cancer?

Gynecologic oncologist Douglas Levine says that progress to find new ways to screen women at average risk for ovarian cancer is slow but steady.

Read Article>


Dana-Farber Cancer Institute| January 7, 2016

Novel Cause of Ovarian Cancer Drug Resistance Identified

Dipanjan Chowdhury, PhD, and Panagiotis Konstantinopoulos, MD, PhD, identified a new resistance mechanism in which ovarian cancer cells turn off one of two competing DNA repair pathways and turn on the other that enables the tumor to resist platinum drugs and PARP inhibitors. Read full article>

Dr. Dipanjan Chowdhury is a Tina’s Wish grant recipient.


PR Newswire | September 24, 2015

Tina’s Wish Benefit Raises $1.4M for Early Detection Ovarian Cancer Research

The legal and financial communities came together once again during Ovarian Cancer Awareness Month to raise $1.4M for The Honorable Tina Brozman Foundation for Ovarian Cancer Research (Tina’s Wish) at its 7th annual benefit dinner held at the American Museum of Natural History.

Read Press Release >


Tina’s Wish | September, 2015

#TealForTinasWish

In honor of Ovarian Cancer Awareness Month, Tina’s Wish is hosting a social media contest that will run through the month of September. One lucky participant will win a teal Fitbit! Participating is easy!

Learn How To Enter >


Dana-Farber Cancer Institute | August, 2015

Joyce Liu, MD, MPH is Honored for Ovarian Cancer Study

Dr. Joyce Liu of the Susan F. Smith Center for Women’s Cancers at Dana-Farber, has been recognized by the Columbia Hospital for Women Research Foundation for having the most influential paper published in 2014 in the field of obstetrics and gynecology. Dr. Liu serves on the Tina’s Wish Scientific Advisory Board

Read Inside the Institute’s Article >

Read More About the Award >


ACC Docket | August, 2015

ACC Announces Winners of 4th Annual “Top 10 30-Somethings”

Laura McLaren, who serves on the Tina’s Wish Junior Committee, is among the 10 outstanding individuals receiving this honor. Ms. McLaren is senior counsel and director at BMO Financial Group, based in Toronto. 

Read Article >


Otterbourg | June 1, 2015

Otterbourg Names Melanie Cyganowski Chair of Restructuring and Bankruptcy Practice

Congratulations to Melanie Cyganowski, Tina’s Wish Women’s Committee Board Member, on being named Chair of Otterbourg’s Restructuring and Bankruptcy Department. 

Read Article >


Inside Chappaqua / Inside Armonk | May 31, 2015

President Bill Clinton Goes to Bat for Tina’s Wish

Grace Bennett’s article captures the impact Tina’s Wish has made by delving into the story behind the organization’s inception, as well as touching upon the multiple monumental achievements it has accomplished.

Read Article >


The Examiner | April 17, 2015

Bill Clinton receives award from Tina’s Wish & Interview with Andrew Brozman

Read Article >


PR Newswire | April 16, 2015

Tina’s Wish Presents Inaugural Global Women’s Health Award to President Bill Clinton 

Tina’s Wish, the only nonprofit organization dedicated exclusively to funding research for the early detection of ovarian cancer, honored President Bill Clinton with the inaugural Tina’s Wish Global Women’s Health Award at a reception at the Waldorf Astoria New York on April 14th. Hundreds attended the event which raised much-needed funds that will benefit Tina’s Wish and its mission to find an effective way to diagnose ovarian cancer at its earliest, most curable stage. 

Read Press Release >


NewsMedical | April 16, 2015

President Bill Clinton honored with inaugural Tina’s Wish Global Women’s Health Award 

Read Article >


The New York Law Journal | April 16, 2015

Tina’s Wish Honors Clinton

Read Article >


The Wall Street Journal | April 15, 2015

Bill Clinton regales New York Bankruptcy Crowd

Read Article >


Forbes | April 15, 2015

Bill Clinton Speaks About Science and Cancer Research at Charity Event 

Read Article >


MSNBC | April 14, 2015

Bill Clinton avoids campaign talk at cancer event

Read Article >


Washington Post | April 14, 2015

In Speech, Bill Clinton makes no mention of wife’s campaign

Read Article >


The Examiner | April 9, 2015

Know Your Neighbor, Andrew Brozman, Attorney/Tina’s Wish Co-founder, Chappaqua

Read Article >


Memorial Sloan Kettering Cancer Center | March 23rd, 2014

Aggressive Ovarian Cancer Mutation Identified

Douglas A. Levine, M.D., Tina’s Wish Researcher and Chair of the Foundation’s Scientific Advisory Committee and board member, and his colleagues, identified a genetic mutation that appears to cause small cell carcinoma of the ovary, hypercalcemic type (SCCOHT), a rare but very aggressive type of ovarian cancer found in young women. The findings were published in Nature Genetics, March 23, 2014. 

See Press Release >


PR Newswire | March 3rd, 2015

Tina’s Wish to Honor President Bill Clinton with Inaugural Global Women’s Health Award

Nonprofit that funds research for early detection of ovarian cancer awards Founder of the Clinton Foundation for supporting the cause of women’s health globally.

See Press Release >


Nature Methods | March 2nd, 2015

High-throughput RNA profiling via up-front sample parallelization

Tina’s Wish Researcher, Abhijit A Patel, assistant professor of therapeutic radiology at the Yale School of Medicine, and his team at Yale Cancer Center have been credited for their recent discovery that will allow for a faster, less expensive way to analyze gene activity. The details of their research and their findings were reported and published in Nature Methods on March 2nd.

Read Article >

YaleNews Press Release >